Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Colombian pneumonia study reveals key infection patterns

NCT ID NCT07354425

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study looked at 688 adults hospitalized with pneumonia in 11 hospitals in Colombia to find out how many cases were caused by pneumococcal bacteria. Researchers also identified which bacterial strains were most common and whether current vaccines cover them. The goal is to help improve vaccination strategies in the region.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

What this could lead to
If successful, this study could help public health officials choose the best pneumococcal vaccine for adults in Colombia.
What could go wrong
This is an observational study, not a treatment trial. It describes what is happening but does not test a new drug or vaccine.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Participants

688 people

The number who actually took part.

Started

Jun 2022

Finished

Feb 2025

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Who is studied

The study population will consist of adults aged 18 years or older hospitalized with community-acquired pneumonia (CAP) in the Sabana Centro region of Colombia. This region includes 11 municipalities around Bogotá and represents a diverse socio-economic and demographic population with a well-organized healthcare system.

Ages

18 years and older

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * (1) Age ≥ 18 years old. * (2) Hospitalized at one of the hospitals of Sabana Centro Region, including both in-patient and observation status stay. * (3) Clinical signs and/or symptoms of an acute respiratory illness, as defined by ≥ 1 of the * following: * -New or worsening shortness of breath in the past 7 days * -New or worsening cough in the past 7 days * -New or worsening sputum production in the past 7 days * -New or worsening chest pain in the past 7 days * -Tachypnea to respiratory rate ≥ 22 breaths/min, not known to be chronic * -Hypoxia to SpO2 ≤ 92% not known to be chronic * -Initiation of invasive or non-invasive mechanical ventilation * (4) Clinical signs and/or symptoms of an acute infection, as defined by ≥ 1 of the following: * -Body temperature ≥ 38º C (100.4º F) or ≤ 35.5º C (95.9º F) * -Reported fever, chills, or feeling feverish at home without explicit documentation of a fever within the past 7 days * -White blood cell count \> 10.7 or \< 3.9 thousand cells/mcL-C-reactive protein \> 10 mg/L * -Altered mental status * (5) Radiologic evidence of pneumonia interpreted by a radiologist, defined as ≥ 1 of the following findings on chest x-ray (CXR), computed tomography (CT), or lung ultrasound completed within 48 hours before or after hospital admission: * -Pulmonary infiltrate not known to be chronic * -Pulmonary opacity is not known to be chronic (including ground-glass opacities on CT) * -Pulmonary consolidation is not known to be Exclusion Criteria: * (1) Enrollment in this study within the past 90 days. * (2) Development of pneumonia (as defined in the inclusion criteria) more than 48 hours after hospital admission (pneumonia developed 48 hours after admission will be considered hospital-acquired pneumonia). * (3) Inability to obtain consent from patient or surrogate for this study within 48 hours of hospital admission (including time at a transferring hospital before admission at a study hospital). * (4) Inability or unwillingness of the patient to provide any of the samples (Blood, Urine, and Sputum) within 48 hours of hospital admission (including time at a transferring hospital before admission at a study hospital). * (5) Non-pneumonia illness completely explains the patient's acute symptoms. Alternative non-pneumonia illnesses could include pulmonary embolism, acute heart failure, lung cancer, and pulmonary hemorrhage.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Community acquired pneumonia (CAP) are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

Community-Acquired Pneumonia pneumonia streptococcal pneumonia

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Centro Medico San Luis Clinica Quirurgica SAS

    Cajicá, Colombia

  • Clinica Universidad de La Sabana

    Chía, Cundinamarca, 250002, Colombia

  • Clinica de Marly Jorge Cavelier Gaviria SAS

    Chía, Cundinamarca, 250002, Colombia

  • ESE Hospital Nuestra Señora del Carmen de Tabio

    Tabio, Colombia

  • ESE Hospital San Antonio de Chia

    Chía, Cundinamarca, 250002, Colombia

  • ESE Hospital San Vicente de Paul Nemocon

    Nemocón, Colombia

  • ESE Hospital Santa Rosa de Tenjo

    Tenjo, Colombia

  • ESE Hospital divino Salvador Sopo

    Sopó, Colombia

  • Hospital Nuestra Señora del Transito de Tocancipa

    Tocancipá, Colombia

  • Hospital Universitario de la Samaritana Regional

    Zipaquirá, Colombia

  • Hospital Universitario de la Samaritana sede Funcional

    Zipaquirá, Colombia

More trials for these conditions

Other studies related to the condition(s) this trial covers.